Analyst Ratings for [ANTX] Anthem, Inc. Corporate Units

8/9/24	Downgrades	In-line Underperform	X
ANTX AN2 Therapeutics Evercore ISI
8/9/24	Downgrades	Outperform Mkt Perform	X
ANTX AN2 Therapeutics Leerink Partners
$5 $1
7/3/24	Upgrades	Mkt Perform Outperform	X
ANTX AN2 Therapeutics Leerink Partners
$5
4/2/24	Upgrades	Mkt Perform Mkt Outperform	X
ANTX AN2 Therapeutics JMP Securities
$6
2/13/24	Downgrades	Outperform Mkt Perform	X
ANTX AN2 Therapeutics Leerink Partners
$23 $7
2/12/24	Downgrades	Outperform In-line	X
ANTX AN2 Therapeutics Evercore ISI
$25 $7
2/12/24	Downgrades	Mkt Outperform Mkt Perform	X
ANTX AN2 Therapeutics JMP Securities
2/12/24	Downgrades	Outperform Perform	X
ANTX AN2 Therapeutics Oppenheimer
1/4/24	Initiated	Mkt Outperform	X
ANTX AN2 Therapeutics JMP Securities
$30
7/18/22	Resumed	Outperform	X
ANTX AN2 Therapeutics Oppenheimer
$22
4/19/22	Initiated	Outperform	X
ANTX AN2 Therapeutics Cowen
4/19/22	Initiated	Outperform	X
ANTX AN2 Therapeutics Oppenheimer
$22

ANTX Anthem, Inc. Corporate Units